Clinical Trial Update: Evaluation of Carboplatin Plus Gemcitabine Followed by Concomitant Chemoradiation for Non-resectable Stage III NSCLC [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial evaluating carboplatin plus gemcitabine followed by concomitant chemoradiation for non-resectable stage III non-small cell lung canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: University Hospital, Antwerp | Conditions: Non-Small-Cell-Lung Cancer | Phase 2 | Status: COMPLETED